John Spertus (@jspertus) 's Twitter Profile
John Spertus

@jspertus

#outcomesresearch

ID: 21699587

calendar_today23-02-2009 22:04:07

139 Tweet

1,1K Followers

149 Following

John Spertus (@jspertus) 's Twitter Profile Photo

So great to see our fellows leveraging their analytic skills to address practical clinical questions and help guide how best to manage patients.

John Spertus (@jspertus) 's Twitter Profile Photo

I applaud UC for drawing attention to this. The quest for profits by Elsevier is impairing the sharing of science, which is our primary goal as researchers and scientists.

Circ: CQO (@circoutcomes) 's Twitter Profile Photo

In a new #MethodsPaper, authors demonstrate how to integrate survival and health status outcomes in a RCT using a joint Bayesian framework #AHAJournals | ow.ly/Nlhp50uD5bi

In a new #MethodsPaper, authors demonstrate how to integrate survival and health status outcomes in a RCT using a joint Bayesian framework #AHAJournals | ow.ly/Nlhp50uD5bi
John Spertus (@jspertus) 's Twitter Profile Photo

Looking forward to discussing #JACC paper about personalizing the decision for PCI vs. CABQ in patients with diabetes and multi-vessel disease.

John Spertus (@jspertus) 's Twitter Profile Photo

So the week of Thanksgiving, the NEJM publishes a study on the benefits of intermittent fasting. On New Year’s they publish a study showing that alcohol abstinence reduces Afib. What are they going to publish on Valentine’s day?? ... Ponderings with Michael Nassif Harlan Krumholz

John Spertus (@jspertus) 's Twitter Profile Photo

Fabulous cutting edge initiative to understand the roles of new technology to improve human health. Thrilled to be part of this ground-breaking study with @CMichealGibson...

John Spertus (@jspertus) 's Twitter Profile Photo

#COVID19 Very concerned about unfounded recommendations to stop ACEI/ARBs in patients with heart disease. Agree with American College of Cardiology and AHA Science that patients need to consider these decisions in close consultation with their doctor. UMKC Saint Luke's Mid America Heart Institute

John Spertus (@jspertus) 's Twitter Profile Photo

Amazing email today for those on satellite internet from Viasat Internet Viasat. In a world where we have to work at home, no break on costs or fees for more access. I used mine up in a week and now on dial-up speed. Just criminal. #makingmoneyfromCovid

Saint Luke's Mid America Heart Institute (@midamericaheart) 's Twitter Profile Photo

The second is from ISCHEMIA-CKD and noted that nearly half of patients had no angina in the prior month. Even in patients with angina, the health status benefit with revascularization was transient and less significant than in the primary ISCHEMIA trial.

The second is from ISCHEMIA-CKD and noted that nearly half of patients had no angina in the prior month. Even in patients with angina, the health status benefit with revascularization was transient and less significant than in the primary ISCHEMIA trial.
Harlan Krumholz (@hmkyale) 's Twitter Profile Photo

Congrats to the #CHIEF_HF investigators…digital first trial, with drug, & for regulatory indication expansion. Canagliflozin improved quality of life in patients with heart failure. But the trial design even bigger news. Heralds new era in trial implementation. John Spertus #AHA21

Congrats to the #CHIEF_HF investigators…digital first trial, with drug, &amp; for regulatory indication expansion. Canagliflozin improved quality of life in patients with heart failure. But the trial design even bigger news. Heralds new era in trial implementation. <a href="/jspertus/">John Spertus</a> #AHA21